Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Protein FAM3B (21-70 aa) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
FAM3B |
Gene ID: |
54097 |
Uniprot ID: |
FAM3B_HUMAN |
Immunogen Region: |
21-70 aa |
Specificity: |
FAM3B Polyclonal Antibody detects endogenous levels of protein. |
Immunogen: |
Synthesized peptide derived from part of the human protein at the amino acid range 21-70 |
Post Translational Modifications | 2 N-termini have been observed in the mature protein: the first at Glu-30, resulting from signal peptide cleavage, the second at Ser-46. O-glycosylated. |
Function | Induces apoptosis of alpha and beta cells in a dose- and time-dependent manner. |
Protein Name | Protein Fam3bCytokine-Like Protein 2-21Pancreatic-Derived FactorPander |
Cellular Localisation | SecretedPresent In Insulin Secretory Granules And Likely Cosecreted With InsulinLocalized In Discrete Vesicular And Perinuclear Structure |
Alternative Antibody Names | Anti-Protein Fam3b antibodyAnti-Cytokine-Like Protein 2-21 antibodyAnti-Pancreatic-Derived Factor antibodyAnti-Pander antibodyAnti-FAM3B antibodyAnti-C21orf11 antibodyAnti-C21orf76 antibodyAnti-PRED44 antibodyAnti-UNQ320 antibodyAnti-PRO365 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance